| 28.10.2024 13:37 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 21.10.2024 12:25 | TSTL | Tristel annual profit surges 40% higher following increase in sales | Alliance |
| 14.10.2024 15:58 | TSTL, CLIG, XPS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 01.10.2024 07:00 | TSTL | Notice of Preliminary Results | RNS |
| 20.09.2024 20:21 | TSTL | IN BRIEF: Tristel CFO Elizabeth Dixon sells 50,000 shares | Alliance |
| 20.09.2024 07:00 | TSTL | Director/PDMR Shareholding | RNS |
| 19.09.2024 13:13 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 02.09.2024 07:00 | TSTL | Confirmation of CEO Transition, Directorate Change | RNS |
| 06.08.2024 15:32 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 22.07.2024 14:33 | TSTL | Tristel reports double-digit revenue growth ahead of targets | Alliance |
| 22.07.2024 07:00 | TSTL | Trading Update | RNS |
| 04.07.2024 15:43 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 11.06.2024 21:52 | TSTL | IN BRIEF: Tristel CEO Swinney and CFO Dixon offload shares | Alliance |
| 11.06.2024 17:48 | TSTL | Director/PDMR Shareholding | RNS |
| 11.06.2024 15:50 | TSTL | Holding(s) in Company | RNS |
| 10.06.2024 09:17 | TSTL | Tristel hires former Lidco CEO to replace founder Paul Swinney at helm | Alliance |
| 10.06.2024 07:00 | TSTL | Appointment of CEO | RNS |
| 08.05.2024 07:00 | TSTL | Tristel™ ULT case study | Reach |
| 07.05.2024 09:51 | AIBG, BIRG, S32 | LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered | Alliance |
| 07.05.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 18.04.2024 12:42 | TSTL | IN BRIEF: Tristel CEO Paul Swinney sells GBP230,000 in shares | Alliance |
| 16.04.2024 14:04 | TSTL | Director/PDMR Shareholding | RNS |
| 15.04.2024 17:56 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 05.04.2024 13:52 | TSTL, LPA, LAND | UK dividends calendar - next 7 days | Alliance |
| 19.03.2024 09:25 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 14.03.2024 15:06 | VSL, TSTL, TENT | UK dividends calendar - next 7 days | Alliance |
| 27.02.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 26.02.2024 09:50 | TSTL | Tristel doubles dividend on revenue and profit boost in first half | Alliance |
| 26.02.2024 07:01 | TSTL | Half-year Report | RNS |
| 26.02.2024 07:00 | TSTL | UK and EU regulatory approval update | RNS |
| 19.02.2024 12:53 | TSTL, MTEC, KOS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 08.02.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 25.01.2024 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 23.01.2024 13:22 | TSTL | Tristel gets approval in Canada for ULT ultrasound disinfectant device | Alliance |
| 23.01.2024 07:00 | TSTL | Canadian regulatory approval for Tristel ULT | RNS |
| 10.01.2024 14:27 | TSTL | Director/PDMR Shareholding | RNS |
| 19.12.2023 12:02 | TSTL | Result of AGM | RNS |
| 19.12.2023 11:47 | TSTL | Tristel optimistic of strong second half following good start to year | Alliance |
| 19.12.2023 07:00 | TSTL | AGM Statement | RNS |
| 15.12.2023 15:58 | TSTL, SEIT, SREI | UK dividends calendar - next 7 days | Alliance |
| 07.12.2023 14:05 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 01.12.2023 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 29.11.2023 12:40 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 07.11.2023 11:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 16.10.2023 10:06 | TSTL | Tristel's annual profit multiplies; outlook "strongest" in 30 years | Alliance |
| 16.10.2023 07:00 | TSTL | Audited Preliminary Results | RNS |
| 12.10.2023 07:00 | TSTL | Additional Investor Presentation | Reach |
| 10.10.2023 16:45 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 09.10.2023 15:45 | TSTL, SEE | UK earnings, trading statements calendar - next 7 days | Alliance |
| 02.10.2023 11:50 | TSTL | Holding(s) in Company | RNS |
| 28.09.2023 14:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 26.09.2023 14:40 | AV., TSTL | Holding(s) in Company | RNS |
| 25.09.2023 08:40 | TSTL | Holding(s) in Company | RNS |
| 22.09.2023 15:40 | AV., TSTL | Holding(s) in Company | RNS |
| 12.09.2023 07:00 | TSTL | Notice of Results | RNS |
| 04.09.2023 14:07 | TSTL | Tristel submits to Health Canada for Tristel ULT medical approval | Alliance |
| 04.09.2023 07:00 | TSTL | Health Canada regulatory approval submission | Reach |
| 15.08.2023 09:28 | TSTL, PFC, BWY | LONDON BROKER RATINGS: Liberum starts Tristel with 'hold' | Alliance |
| 31.07.2023 08:05 | TSTL | Holding(s) in Company | RNS |
| 28.07.2023 14:17 | TSTL | IN BRIEF: Tristel CEO Paul Swinney sells GBP350,000 in shares | Alliance |
| 28.07.2023 08:28 | TSTL | Director/PDMR Shareholding | RNS |
| 25.07.2023 10:56 | TSTL | Tristel annual revenue and profit up thanks to robust demand | Alliance |
| 25.07.2023 07:00 | TSTL | Trading update | RNS |
| 18.07.2023 15:43 | UTG, ULVR, TSTL | UK earnings, trading statements calendar - next 7 days | Alliance |
| 12.07.2023 07:00 | TSTL | Shareholder Open Day and Notice of Trading Update | RNS |
| 10.07.2023 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 26.06.2023 07:00 | TSTL | Director/PDMR Shareholding | RNS |
| 22.06.2023 16:01 | AV., TSTL | Holding(s) in Company | RNS |
| 16.06.2023 07:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 14.06.2023 16:10 | AV., TSTL | Holding(s) in Company | RNS |
| 06.06.2023 17:00 | TSTL | Exercise of Share Options and Total Voting Rights | RNS |
| 05.06.2023 10:26 | TSTL, DXRX, BBB | AIM WINNERS & LOSERS: Tristel hails FDA approval of ULT disinfectant | Alliance |
| 05.06.2023 10:24 | TSTL | Tristel shares soar amid US FDA approval for ultrasound disinfectant | Alliance |
| 05.06.2023 10:00 | TSTL | Analyst and Investor presentation | RNS |
| 05.06.2023 07:00 | TSTL | FDA De Novo approval | RNS |
